Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The SWITCH-COVID trial will randomize patients with COVID-19 that are currently using renin-angiotensin system inhibitors for treating hypertension to maintain the therapy during in-hospital stay or switch the therapy to other antihypertensive classes.
Description: Combined of need for ICU or mortality
Measure: Need for ICU or mortality Time: 30 daysDescription: Evaluate correlation between hs-TnT and covid-19 severity
Measure: High sensitivity troponin levels and covid-19 severity Time: 30 daysDescription: Evaluate correlation of ACE-2 activity and disease severity
Measure: ACE-2 activity and disease severity Time: 30 daysDescription: Evaluate correlation of ACE-2 activity and Renin-angiotensin system inhibitors
Measure: ACE-2 activity with different Renin-angiotensin system inhibitors Time: 30 daysDescription: Evaluate blood pressure control and acute renal failure in each arm (safety)
Measure: Blood control and acute renal failure Time: 30 days